Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular Diseases in Central and Eastern Europe: A Call for More Surveillance and Evidence-Based Health Promotion
Narine Movsisyan, Manlio Vinciguerra, José R. Medina‐Inojosa, et al.
Annals of Global Health (2020) Vol. 86, Iss. 1
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Birgit Vogel, Mónica Acevedo, Yolande Appelman, et al.
The Lancet (2021) Vol. 397, Iss. 10292, pp. 2385-2438
Closed Access | Times Cited: 903
Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017
Maedeh Amini, Farid Zayeri, Masoud ‎Salehi
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 467
STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe
Melanie Grehn, Stefano Mandija, Marcin Miszczyk, et al.
EP Europace (2023) Vol. 25, Iss. 4, pp. 1284-1295
Open Access | Times Cited: 42
Future Perspectives in Small-Diameter Vascular Graft Engineering
Panagiotis Mallis, Alkiviadis Kostakis, Catherine Stavropoulos‐Giokas, et al.
Bioengineering (2020) Vol. 7, Iss. 4, pp. 160-160
Open Access | Times Cited: 82
Application of decellularized vascular matrix in small-diameter vascular grafts
Yuanming Li, Ying Zhou, Weihua Qiao, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 10
Open Access | Times Cited: 22
Cardiovascular disease prevention and management in the COVID-19 era and beyond: An international perspective
Mark A. Faghy, James Yates, Andrew P. Hills, et al.
Progress in Cardiovascular Diseases (2023) Vol. 76, pp. 102-111
Open Access | Times Cited: 21
Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study
Michal Vráblík, Bohumil Seifert, Alexander Parkhomenko, et al.
Atherosclerosis (2021) Vol. 334, pp. 66-75
Closed Access | Times Cited: 54
Assessing the relationship between sex, gender, and hypertension: A federated analysis of European and Canadian Public Health Surveys
Zahra Azizi, Simon D. Linder, María del Carmen Macías Ruiz, et al.
Medicine (2025) Vol. 104, Iss. 6, pp. e41021-e41021
Open Access
The Role of Dietary Education in Cardiac Rehabilitation
Joanna Popiołek-Kalisz, M.J. Mazur, Francesco Perone
Nutrients (2025) Vol. 17, Iss. 6, pp. 1082-1082
Open Access
Ambient air pollution and risk of hospital admission due to acute and chronic coronary syndromes: a time-stratified case-crossover study in the 3 largest urban agglomerations in Poland
Piotr Dąbrowiecki, Ewa Konduracka, Łukasz Kołtowski, et al.
Polskie Archiwum Medycyny Wewnętrznej (2025)
Open Access
National Trends in Racial and Ethnic Disparities in Mortality from Mechanical Complications of Cardiac Valves and Grafts (1999–2020)
Ye In Christopher Kwon, David T. Zhu, Alan Lai, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 562-562
Open Access
Histone H2A: a promising diagnostic marker in heart failure with reduced versus preserved ejection fraction
Desislava K. Tsoneva, Diana Búzová, Salvatore Daniele Bianco, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017
Haijiang Dai, Dor Lotan, Arsalan Abu‐Much, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 29
Could Artificial Intelligence/Machine Learning and Inclusion of Diet-Gut Microbiome Interactions Improve Disease Risk Prediction? Case Study: Coronary Artery Disease
Baiba Vilne, Juris Ķibilds, Inese Siksna, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 20
Prevalence, awareness, treatment and control of hypertension, diabetes and hypercholesterolemia, and associated risk factors in the Czech Republic, Russia, Poland and Lithuania: a cross-sectional study
Wentian Lu, Hynek Pikhart, Abdonas Tamošiūnas, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Epidemiological Trends in Cardiovascular Disease Mortality Attributable to Modifiable Risk Factors and Its Association with Sociodemographic Transitions across BRICS-Plus Countries
Nawsherwan Nawsherwan, Sumaira Mubarik, Bin Wang, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3757-3757
Open Access | Times Cited: 10
Heart failure care in the Central and Eastern Europe and Baltic region: status, barriers, and routes to improvement
Ovidiu Chioncel, Jelena Čelutkienė, Jan Bělohlávek, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 4, pp. 1861-1874
Open Access | Times Cited: 3
Trends in atrial fibrillation-related mortality in Europe, 2008–2019
Marco Zuin, Michele Malagù, Francesco Vitali, et al.
European Heart Journal - Quality of Care and Clinical Outcomes (2024) Vol. 10, Iss. 5, pp. 467-478
Closed Access | Times Cited: 3
Impact of the 2021 European Society for Cardiology prevention guideline’s stepwise approach for cardiovascular risk factor treatment in patients with established atherosclerotic cardiovascular disease
J Holtrop, Deepak L. Bhatt, Kausik K. Ray, et al.
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 6, pp. 754-762
Open Access | Times Cited: 3
Comparative risk assessment for the development of cardiovascular diseases in the Hungarian general and Roma population
Péter Pikó, Zsigmond Kósa, János Sándor, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
To What Extent Does Cardiovascular Risk Classification of Patients with Type 2 Diabetes Differ between European Guidelines from 2023, 2021, and 2019? A Cross-Sectional Study
Silvia Ana Luca, Raluca Malina Bungau, Sandra Lazăr, et al.
Medicina (2024) Vol. 60, Iss. 2, pp. 334-334
Open Access | Times Cited: 2
Development and Validation of an HPLC-MS/MS Method for the Quantitative Determination of Etmaben in Human Blood Plasma
P. K. Karnakova, Т. Н. Комаров, O. A. Archakova, et al.
Drug development & registration (2024) Vol. 13, Iss. 1, pp. 257-271
Open Access | Times Cited: 2
Lipid-Derived Biomarkers as Therapeutic Targets for Chronic Coronary Syndrome and Ischemic Stroke: An Updated Narrative Review
Thomas Gabriel Schreiner, Bogdan Ignat, Cristina Grosu, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 561-561
Open Access | Times Cited: 2
Patient vulnerability in stereotactic arrhythmia radioablation (STAR): a preliminary ethical appraisal from the STOPSTORM.eu consortium
Carlo Botrugno, Chiara Crico, Mauro Iori, et al.
Strahlentherapie und Onkologie (2024) Vol. 200, Iss. 10, pp. 903-907
Open Access | Times Cited: 2
The Cold War in pharmacology: a bibliometric analysis of Berlin’s contributions to Naunyn‑Schmiedeberg’s Archives of Pharmacology (1947–1974)
Mert Erkan Basol, Roland Seifert
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 10, pp. 7963-7980
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top